Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Sarepta Therapeutics (NASDAQ: SRPT)

$29.68 USD -$0.51 (-1.69%)
Last Price $29.68
Net Change $-0.51 (-1.69%)
Bid $29.41
Ask Price $29.92
Open Price $30.06
Previous Close Price $30.19
High Price $30.55
Low Price $29.52
Number of Trades 4,927
Volume 1,043,211
Fifty Two Week High $63.73 (2016-09-28)
Fifty Two Week Low $8 (2016-04-26)
Average Daily Volume 2,665,188
Share Outstanding 54,810 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.71 (2017-02-28)
2nd Quarter Earnings $-0.95 (2016-10-27)
3nd Quarter Earnings $-1.19 (2016-07-19)
4th Quarter Earnings $-1.15 (2016-05-05)
PE Ratio $0
EPS Growth $44.23
Recent Earnings $-0.71
Annual EPS $-5.33
Last Quarter EPS $
Market Capitalization $1.63B
Insider Shareholders % 0.109%
Annual Revenue $0B
No. Shares Outstanding 54,810
Inst. Shareholder % 71.97%
Annual Net Income $-0.27B
TTM Net Profit Margin $-4931
1-Year Return 64.88%
3-Year Return 23.02%
5-Year Return 214.48%
5-Year Revenue Growth -88.47%
5-Year Earnings Growth 4400%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 44.23%
Dividends per Share $
Stock Split Ratio 1-6
Beta 1.79
Sarepta Therapeutics Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen for Duchenne muscular dystrophy. Sarepta Therapeutics Inc. formerly known as AVI BioPharma Inc. is headquartered in Bothell Washington.